This inventor holds 1 USPTO granted patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 1978.
Company Filing History:
Years Active: 1978
Title: Sherwin Wilk: Innovator in Renal Health
Introduction
Sherwin Wilk is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in renal health. His innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Sherwin Wilk holds a patent for the synthesis and use of L-.gamma.-glutamyl-DOPA. This invention focuses on the synthesis of L-.gamma.-glutamyl-DOPA (L-.gamma.-glutamyl-L-3,4-dihydroxy-phenylalanine) and its application in selectively increasing renal blood flow in mammals. This advancement has the potential to improve treatments related to kidney function and overall renal health.
Career Highlights
Wilk is affiliated with the Icahn School of Medicine at Mount Sinai, where he continues to engage in research and innovation. His work in this esteemed institution has allowed him to explore various aspects of medical science and contribute to advancements in healthcare.
Collaborations
One of his notable collaborators is Marian Orlowski. Together, they have worked on projects that aim to enhance medical treatments and improve patient outcomes.
Conclusion
Sherwin Wilk's contributions to renal health through his patent and research at the Icahn School of Medicine at Mount Sinai highlight his dedication to innovation in medicine. His work continues to pave the way for advancements in healthcare.